Here on MiraKind.org, we’ve already discussed how the KRAS-variant plays a role in breast cancer risk, ovarian cancer risk, effects of HRT in the KRAS-variant patients, and even autoimmunity! Now, we want…
Read More
In May, Dr. Joanne Weidhaas did a webinar and Q&A session with members of our MiraKind community to share how MiraKind was using its available resources to help increase testing availability for…
Read More
Program Expands Efforts by Los Angeles-based Molecular Genetics Company MiraDx to Provide COVID-19 Tests to Essential Workers via Philanthropic Donations to its Sister Non-Profit LOS ANGELES (April 13, 2020) — Mirakind.org, a…
Read More
MiraKind is ready to distribute COVID-19 tests for free to essential workers, with funding from the generous philanthropic donations of our MiraKind community through our #330MillionTests.org site. We are currently prioritizing access…
Read More
At MiraKind, we believe knowledge is power. That belief has never held truer than today, as we face a global pandemic that can only be stamped out with knowledge–knowledge of who is…
Read More
Our founder, Dr. Joanne Weidhaas will be giving her first “TED talk” as an invited speaker at TEDxCulverCity on March 31, 2020! Joanne is a radiation oncologist and cancer researcher, and she…
Read More
We want to start with the basics about Hormone Replacement Therapy, so you can get up to speed on the importance of MiraKind’s new study. In this article, we’ll cover what Hormone…
Read More
MiraKind is committed to providing our community with the best tools possible to tackle challenges in the arena of women’s health. This is why MiraKind is partnering with genneve, a first-of-its-kind telehealth…
Read More
When our team came across a recent Los Angeles Times Article entitled, “Once and for all: Hormone replacement is good for women” we were very intrigued. What we learned from this game-changing…
Read More
A new study by MiraKind’s Founder, Dr. Joanne Weidhaas, in collaboration with her team at the University of California, Los Angeles and City of Hope, has been published in the scientific journal…
Read More
As discussed in our previous Genetics series posts, the discovery of non-coding RNAs paved the way for changes in the Central Dogma and how we think about the flow of genetic information…
Read More
The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we’ve spoken a lot…
Read More